Differences in the prevalence of colorectal polyps in patients undergoing endoscopic removal of gastric adenoma or early gastric cancer and in healthy individuals

Background and aims: We compared the prevalence of adenomatous and cancerous colon polyps in patients who underwent endoscopic removal of gastric neoplasms and in healthy controls.

Materials and methods: This retrospective study reviewed the medical records of 186 patients with gastric neoplasms and 186 healthy subjects from January 2002 to October 2008. The gastric neoplasm group was comprised of patients undergoing endoscopic removal of gastric adenomas or early gastric cancers and serial fiberoptic colonoscopy (FCS) for checkups. The control group was comprised of subjects undergoing fiberoptic esophagogastroduodenoscopy (FEGD) and FCS for general checkup and was matched for age and sex with the gastric neoplasm group. Advanced colonic neoplasm was defined by any of the following: (1) the presence of three or more polyps; (2) polyp size at least 1.0 cm; (3) high-grade dysplasia or adenocarcinoma confirmed by histopathologic examination.

Results: Of the 372 persons, colorectal polyps were detected in 124 (33.3 %), advanced colonic neoplasms in 44 (11.8 %), and adenocarcinomas in 10 (2.7 %). The overall prevalence of adenomatous or cancerous polyps (”all polyps“) and the prevalence of advanced colonic neoplasms were significantly higher in the gastric neoplasm group than in the control group (all polyps: 40.9 % in the gastric neoplasm group vs. 25.8 % in the control group, P = 0.002; advanced colonic neoplasms: 15.6 % vs. 8.1 %, P = 0.025). The risk factors for all polyps were age, male sex, diabetes mellitus, and being assigned to the gastric neoplasm group, and those for advanced colonic neoplasms were age and being assigned to the gastric neoplasm group. Confining the analysis to the gastric neoplasm group, the risk factors for all polyps were identical with those for the total group; however, those for advanced colonic neoplasm were different (age vs. diabetes and hypertriglyceridemia).

Conclusion: Endoscopists should consider performing routine FCS in patients undergoing endoscopic removal of gastric neoplasms.

References

• 1 Isomoto H, Shikuwa S, Yamaguchi N. et al . Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study.  Gut. 2009;  58 331-336
• 2 Onozato Y, Ishihara H, Iizuka H. et al . Endoscopic submucosal dissection for early gastric cancers and large flat adenomas.  Endoscopy. 2006;  38 980-986
• 3 Ohnita K, Isomoto H, Yamaguchi N. et al . Factors related to the curability of early gastric cancer with endoscopic submucosal dissection.  Surg Endosc. 2009;  Epub ahead of print
• 4 Ueno M, Muto T, Oya M. et al . Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer.  Int J Clin Oncol. 2003;  8 162-167
• 5 Arai T, Sawabe M, Takubo K, Kanazawa K, Esaki Y. Multiple colorectal cancers in the elderly: a retrospective study of both surgical and autopsy cases.  J Gastroenterol. 2001;  36 748-752
• 6 Eom B W, Lee H J, Yoo M W. et al . Synchronous and metachronous cancers in patients with gastric cancer.  J Surg Oncol. 2008;  98 106-110
• 7 Ikeda Y, Saku M, Kawanaka H, Nonaka M, Yoshida K. Features of second primary cancer in patients with gastric cancer.  Oncology. 2003;  65 113-117
• 8 Lee J H, Bae J S, Ryu K W. et al . Gastric cancer patients at high risk of having synchronous cancer.  World J Gastroenterol. 2006;  12 2588-2592
• 9 Lim S B, Jeong S Y, Choi H S. et al . Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea.  Int J Colorectal Dis. 2008;  23 61-65
• 10 Tomoda H, Taketomi A, Baba H. et al . Multiple primary colorectal and gastric carcinoma in Japan.  Oncol Rep. 1998;  5 147-149
• 11 Yamamoto S, Yoshimura K, Ri S. et al . The risk of multiple primary malignancies with colorectal carcinoma.  Dis Colon Rectum. 2006;  49 S30-S36
• 12 Georgopoulos S D, Polymeros D, Triantafyllou K. et al . Hypergastrinemia is associated with increased risk of distal colon adenomas.  Digestion. 2006;  74 42-46
• 13 Luzzi I, Pezzella C, Caprioli A. et al . Detection of vacuolating toxin of Helicobacter pylori in human faeces.  Lancet. 1993;  341 1348
• 14 Shmuely H, Passaro D, Figer A. et al . Relationship between Helicobacter pylori CagA status and colorectal cancer.  Am J Gastroenterol. 2001;  96 3406-3410
• 15 Breuer-Katschinski B, Nemes K, Marr A. et al . Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group.  Digestion. 1999;  60 210-215
• 16 Lee K S, Kim H Y, Lee J Y. et al . Can Helicobacter pylori infection cause upper gastrointestinal and colonic lesions simultaneously?.  Korean J Gastrointest Endosc. 2001;  22 14-20
• 17 Machida-Montani A, Sasazuki S, Inoue M. et al . Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study.  Helicobacter. 2007;  12 328-332
• 18 Mizuno S, Morita Y, Inui T. et al . Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy.  Int J Cancer. 2005;  117 1058-1059
• 19 Siddheshwar R K, Muhammad K B, Gray J C, Kelly S B. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma.  Am J Gastroenterol. 2001;  96 84-88
• 20 WHO Expert Consultation . Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.  Lancet. 2004;  363 157-163
• 21 Winawer S J, Zauber A G, Fletcher R H. et al . Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.  Gastroenterology. 2006;  130 1872-1885
• 22 Sontag S J, Schnell T G, Chejfec G. et al . Barrett’s oesophagus and colonic tumours.  Lancet. 1985;  1 946-949
• 23 Siersema P D, Yu S, Sahbaie P. et al . Colorectal neoplasia in veterans is associated with Barrett’s esophagus but not with proton-pump inhibitor or aspirin/NSAID use.  Gastrointest Endosc. 2006;  63 581-586
• 24 Jun D W, Lee O Y, Lim H C. et al . Role of computed tomographic colonoscopy of postoperative surveillance in patient with gastric cancer.  World J Gastroenterol. 2007;  13 1646-1651
• 25 Oh S Y, Park D I, Yoo T W. et al . Is gastric cancer a new indication for surveillance colonoscopy? Colon cancer is increased in gastric cancer patients.  Korean J Gastroenterol. 2006;  47 191-197
• 26 Meucci G, Tatarella M, Vecchi M. et al . High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas.  J Clin Gastroenterol. 1997;  25 605-607
• 27 Sobhani I, Lehy T, Laurent-Puig P. et al . Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa.  Gastroenterology. 1993;  105 22-30
• 28 Winawer S, Fletcher R, Rex D. et al . Colorectal cancer screening and surveillance: clinical guidelines and rationale – update based on new evidence.  Gastroenterology. 2003;  124 544-560
• 29 Nakatsuru S, Yanagisawa A, Ichii S. et al . Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma.  Hum Mol Genet. 1992;  1 559-563
• 30 Uchino S, Noguchi M, Ochiai A. et al . p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer.  Int J Cancer. 1993;  54 759-764
• 31 Uchino S, Tsuda H, Noguchi M. et al . Frequent loss of heterozygosity at the DCC locus in gastric cancer.  Cancer Res. 1992;  52 3099-3102
• 32 Ohtani H, Yashiro M, Onoda N. et al . Synchronous multiple primary gastrointestinal cancer exhibits frequent microsatellite instability.  Int J Cancer. 2000;  86 678-683
• 33 Lieberman D A, Prindiville S, Weiss D G, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.  JAMA. 2003;  290 2959-2967